Gilead Sciences Inc Annual Shareholders Meeting Transcript
Good day, and welcome to Gilead's 2020 Annual Meeting of Stockholders. I would now like to turn the conference over to Daniel O'Day, Chairman of the Board and Chief Executive Officer of Gilead Sciences. Please go ahead.
' -
Well, good morning, everybody. I'm Dan O'Day, Chairman of the Board and Chief Executive Officer of Gilead Sciences. I'm pleased to welcome you to Gilead's 2020 Annual Meeting of Stockholders. Due to the COVID-19 pandemic and to support the health and safety of our stockholders, employees, Board of Directors and surrounding communities, we are holding this meeting in a virtual-only format instead of an in-person meeting. We have stockholders and participants attending via the virtual meeting portal.
Before I call the meeting to order, I'd like to introduce you to some of the members of the Gilead team. Joining me today are members of the Board of Directors. We have John Cogan, our Lead Independent Director; Jacqueline Barton; Sandra Horning; Kelly Kramer; Kevin
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |